Transarterial Chemoembolization of Hepatocellular Carcinoma: Propensity Score Matching Study Comparing Survival and Complications in Patients with Nonalcoholic Steatohepatitis Versus Other Causes Cirrhosis

被引：0
|
作者：
Shamar Young
Tina Sanghvi
Nathan Rubin
Damian Hall
Luke Roller
Yassine Charaf
Jafar Golzarian
机构：
[1] University of Minnesota,Department of Radiology, Division of Interventional Radiology
[2] Minneapolis VA Health Care System,VA Department of Radiology
来源：
CardioVascular and Interventional Radiology | 2020年 / 43卷
关键词：
Nonalcoholic fatty liver disease; Chemoembolization; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 75
页数：10
相关论文
共 50 条
  • [31] Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study
    Zhang, Ke
    Mu, Lei
    Ren, Yiyue
    Jiang, Tianan
    EUROPEAN JOURNAL OF RADIOLOGY, 2023, 167
  • [32] Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma
    Yuan, Bao-Hong
    Yuan, Wei-Ping
    Li, Ru-Hong
    Xiang, Bang-De
    Gong, Wen Feng
    Li, Le-Qun
    Zhong, Jian-Hong
    TUMOR BIOLOGY, 2016, 37 (02) : 2435 - 2441
  • [33] Tumor feeding artery contraction and metastasis inhibition after transarterial chemoembolization combined with apatinib for hepatocellular carcinoma: A propensity score matching study
    Cao, Yanyan
    Kan, Xuefeng
    Chen, Lei
    Sun, Tao
    Ouyang, Tao
    Zhang, Weihua
    Xiong, Fu
    Liang, Bin
    Zheng, Chuansheng
    HEPATOLOGY RESEARCH, 2022, 52 (06) : 546 - 556
  • [34] Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study
    Lang, Mengran
    Gan, Leijuan
    Ren, Shaohua
    Han, Ruyu
    Ma, Xiaochen
    Li, Guangtao
    Li, Huikai
    Zhang, Ti
    Wu, Qiang
    Cui, Yunlong
    Zhang, Wei
    Fang, Feng
    Li, Qiang
    Lu, Wei
    Song, Tianqiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06): : 2540 - +
  • [35] Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis
    Su, Chien-Wei
    Fang, Kuan-Chieh
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chen, Ping-Hsien
    Lee, Pei-Chang
    Kao, Wei-Yu
    Huang, Yi-Hsiang
    Huo, Teh-Ia
    Hou, Ming-Chih
    Lin, Han-Chieh
    Wu, Jaw-Ching
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (02) : 610 - 620
  • [36] Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: A propensity score matching analysis
    Zhao, Jianping
    Wang, Jingjing
    Lu, Yuanxiang
    Wu, Yang
    Kuang, Dong
    Wang, Ying
    Luo, Hongchang
    Xu, Anhui
    Zhang, Wanguang
    EJSO, 2023, 49 (12):
  • [37] Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3-5 cm: A propensity score matching study
    Li, Minpeng
    He, Jun
    Pan, Meng
    Yu, Yuan
    Pan, Zhuang
    Xu, Bin
    Zhu, Jiye
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (09) : 1082 - 1087
  • [38] Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study
    Li, Xin
    Chen, Baohua
    An, Chao
    Cheng, Zhigang
    Han, Zhiyu
    Liu, Fangyi
    Yu, Jie
    Liang, Ping
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (05) : 1027 - 1037
  • [39] Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study
    Peng, Tzu-Rong
    Wu, Ta-Wei
    Wu, Chao-Chuan
    Chang, Sou-Yi
    Chan, Cheng-Yi
    Hsu, Ching-Sheng
    TZU CHI MEDICAL JOURNAL, 2022, 34 (02): : 219 - 225
  • [40] Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study
    Zhao, Chenghao
    Xiang, Zhanwang
    Li, Mingan
    Wang, Haofan
    Liu, Huan
    Yan, Huzheng
    Huang, Mingsheng
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1195 - 1206
12345